Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer

被引：0
|
作者：
Jörg Tamihardja
Sinan Cirsi
Patrick Kessler
Gary Razinskas
Florian Exner
Anne Richter
Bülent Polat
Michael Flentje
机构：
[1] University of Wuerzburg,Department of Radiation Oncology
来源：
Radiation Oncology | / 16卷
关键词：
Adaptive radiotherapy; Deformable image registration; Dominant intraprostatic lesion; Dose accumulation; Prostate cancer; Prostate Imaging Reporting and Data System;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer
    Tamihardja, Joerg
    Cirsi, Sinan
    Kessler, Patrick
    Razinskas, Gary
    Exner, Florian
    Richter, Anne
    Polat, Bulent
    Flentje, Michael
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [2] Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer
    Abe, Eisuke
    Mizowaki, Takashi
    Norihisa, Yoshiki
    Narita, Yuuichirou
    Matsuo, Yukinori
    Narabayashi, Masaru
    Nagata, Yasushi
    Hiraoka, Masahiro
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2010, 11 (04): : 144 - 154
  • [3] Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy
    Wang, Bin
    Wang, Da Quan
    Lin, Mao Sheng
    Lu, Shi Pei
    Zhang, Jun
    Chen, Li
    Li, Qi Wen
    Cheng, Zhang Kai
    Liu, Fang Jie
    Guo, Jin Yu
    Liu, Hui
    Qiu, Bo
    BMC CANCER, 2020, 20 (01)
  • [4] Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients?
    Yildirim, Berna A.
    Onal, Cem
    Dolek, Yemliha
    JAPANESE JOURNAL OF RADIOLOGY, 2017, 35 (01) : 3 - 9
  • [5] Evaluation of safety margins for cone beam CT-based adaptive prostate radiotherapy
    Dupont, Florian
    Dechambre, David
    Sterpin, Edmond
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2024, 121
  • [6] Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy
    Bin Wang
    Da Quan Wang
    Mao Sheng Lin
    Shi Pei Lu
    Jun Zhang
    Li Chen
    Qi Wen Li
    Zhang Kai Cheng
    Fang Jie Liu
    Jin Yu Guo
    Hui Liu
    Bo Qiu
    BMC Cancer, 20
  • [7] Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion: a plan comparison
    Cambria, Raffaella
    Ciardo, Delia
    Bazani, Alessia
    Pansini, Floriana
    Rondi, Elena
    Maestri, Davide
    Zerini, Dario
    Marvaso, Giulia
    Romanelli, Pola
    Timon, Giorgia
    Fodor, Cristiana
    Petralia, Giuseppe
    Alessi, Sarah
    Pricolo, Paola
    Vischioni, Barbara
    Fossati, Piero
    Molinelli, Sivia
    Russo, Stefania
    Ciocca, Mario
    De Cobelli, Ottavio
    Renne, Giuseppe
    Orecchia, Roberto
    Cattani, Federica
    Jereczek-Fossa, Barbara A.
    TUMORI JOURNAL, 2022, 108 (03): : 263 - 269
  • [8] MRI-guided localization of the dominant intraprostatic lesion and dose analysis of volumetric modulated arc therapy planning for prostate cancer
    Tamihardja, Joerg
    Zenk, Maria
    Flentje, Michael
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (02) : 145 - 152
  • [9] Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients?
    Berna A. Yildirim
    Cem Onal
    Yemliha Dolek
    Japanese Journal of Radiology, 2017, 35 : 3 - 9
  • [10] Stereotactic body radiotherapy (SIB-VMAT technique) to dominant intraprostatic lesion (DIL) for localized prostate cancer: a dose-escalation trial (DESTROY-4).
    Francesco Deodato
    Milena Ferro
    Paolo Bonome
    Donato Pezzulla
    Carmela Romano
    Milly Buwenge
    Savino Cilla
    Alessio Giuseppe Morganti
    Gabriella Macchia
    Strahlentherapie und Onkologie, 2024, 200 : 239 - 249
12345